EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

The nuclear receptor LRH ‐1 discriminates between ligands using distinct allosteric signaling circuits

Suzanne G Mays iD, David Hercules, Eric A Ortlund iD, C Denise Okafor iD

Protein Science · 2023-10 · 32 (10)

DOI: 10.1002/pro.4754 ↗

At a glance

Journal article in Protein Science, published online on 2023-09-20. Written by Suzanne G Mays and 3 co-authors. Institution: Department of Biochemistry, Emory University, Atlanta, Georgia, USA. Major MEDLINE topics: Receptors, Cytoplasmic and Nuclear, Transcription Factors. Cited 10 times so far (Crossref); 57 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NIDDK NIH HHS, Burroughs Wellcome Fund, National Institutes of Health.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Nuclear receptors (NRs) are transcription factors that regulate essential biological processes in response to cognate ligands. An important part of NR function involves ligand‐induced conformational changes that recruit coregulator proteins to the activation function surface (AFS), ~15 Å away from the ligand‐binding pocket. Ligands must communicate with the AFS to recruit appropriate coregulators and elicit different transcriptional outcomes, but this communication is poorly understood. These studies illuminate allosteric communication networks underlying activation of liver receptor homolog‐1 (LRH‐1), a NR that regulates development, metabolism, cancer progression, and intestinal inflammation. Using >100 μs of all‐atom molecular dynamics simulations involving 74 LRH‐1 complexes, we identify distinct signaling circuits used by active and inactive ligands for AFS communication. Inactive ligands communicate via strong, coordinated motions along paths through the receptor to the AFS. Activating ligands disrupt the “inactive” circuit and induce connectivity with a second allosteric site. Ligand‐contacting residues in helix 7 help mediate the switch between circuits, suggesting new avenues for developing LRH‐1‐targeted therapeutics. We also elucidate aspects of coregulator signaling, showing that localized, destabilizing fluctuations are induced by inappropriate ligand‐coregulator pairings. These studies have uncovered novel features of LRH‐1 allostery, and the quantitative approach used to analyze many simulations provides a framework to study allosteric signaling in other receptors.

Subjects

MeSH terms (MEDLINE)

Receptors, Cytoplasmic and NuclearTranscription FactorsLigandsMolecular Dynamics SimulationAllosteric SiteProtein Binding

Author keywords

LRH-1allosteric regulationligand regulationmolecular dynamicsnuclear receptorstructure-function

Substances

LigandsReceptors, Cytoplasmic and NuclearTranscription Factors

Authors and institutions

  • Department of Biochemistry, Emory University, Atlanta, Georgia, USA.
  • Department of Genome Biology, Centre for Genomic Regulation, Barcelona, Spain.
  • Department of Molecular Biology and Biochemistry, Pennsylvania State University, State College, Pennsylvania, USA.

ORCID profiles: Suzanne G Mays, Eric A Ortlund, C Denise Okafor

Funding

  • NIDDK NIH HHS
  • Burroughs Wellcome Fund
  • National Institutes of Health

Cite

APA

Mays, S. G., Hercules, D., Ortlund, E. A., & Okafor, C. D. (2023). The nuclear receptor LRH ‐1 discriminates between ligands using distinct allosteric signaling circuits. Protein Science, 32(10). https://doi.org/10.1002/pro.4754

Vancouver

Mays SG, Hercules D, Ortlund EA, Okafor CD. The nuclear receptor LRH ‐1 discriminates between ligands using distinct allosteric signaling circuits. Protein Science. 2023;32(10). doi:10.1002/pro.4754

BibTeX
@article{Mays2023,
  author = {Mays, Suzanne G and Hercules, David and Ortlund, Eric A and Okafor, C Denise},
  title = {The nuclear receptor LRH ‐1 discriminates between ligands using distinct allosteric signaling circuits},
  journal = {Protein Science},
  year = {2023},
  volume = {32},
  number = {10},
  doi = {10.1002/pro.4754}
}
Start for free →